GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
3.190
+0.180 (5.98%)
Nov 20, 2024, 4:00 PM EST - Market closed
GT Biopharma Employees
GT Biopharma had 2 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$6,174,500
Market Cap
7.13M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CareMax | 1,450 |
Cutera | 430 |
Aptose Biosciences | 36 |
Healthcare Triangle | 31 |
Brainstorm Cell Therapeutics | 29 |
Addex Therapeutics | 23 |
BioCardia | 20 |
Organovo Holdings | 20 |
GTBP News
- 6 days ago - GT Biopharma Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 7 weeks ago - GT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
- 2 months ago - GT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024 - GlobeNewsWire
- 5 months ago - GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia - GlobeNewsWire
- 6 months ago - GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 6 months ago - What made GT Biopharma stock more than double on Monday? - Invezz
- 6 months ago - GT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 8 months ago - GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results - GlobeNewsWire